CTRI/2017/02/007766招募中未知
To compare the efficacy and safety of Vildagliptin and Teneligliptin in patients with Type 2 Diabetes Mellitus
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 入组人数
- 160
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Newly diagnosed type 2 Diabetes mellitus
- •poorly controlled diabetics on oral hypoglycemic agents
排除标准
- •Patients on insulin
- •Diabetic Ketoacidosis
- •Diabetic Nephropathy
- •Septicaemia
- •Psychotic Patients
- •Known case of HIV/HBs Ag/HCV and immunocompromised patients
研究者
相似试验
未知
3 期
To Compare the Efficacy and Safey of Vildagliptin Compared to Voglibose in Patients With Type 2 DiabetesType 2 DiabetesJPRN-jRCT2080220294ovartis Pharma K.K.370
招募中
4 期
An study to assess the safety and efficacy of vildagliptin vs voglibose in management of post-prandial blood sugar in patients with T2DMCTRI/2024/08/072355Dr Mahima V
已完成
4 期
Comparison of utility of Viladagliptin 50 mg tablet twice daily and metformin combination therapy with Vildagliptin 100 mg sustained release tablet once daily and metformin combination therapy in Indian patients with type 2 diabetes mellitus: A randomized open label phase IV clinical trialCTRI/2021/10/037574Dr Rudra Paul
未知
3 期
To assess the efficacy and safety of vildagliptin as add-on therapy to sulfonylurea in patients with type 2 diabetes inadequately controlled with sulfonylurea monotherapyType 2 DiabetesJPRN-jRCT2080220244ovartis Pharma K.K.200
未知
1 期
To Assess the Efficacy and Safety of Vildagliptin in Patients with Type 2 DiabetesType 2 DiabetesJPRN-jRCT2080220150ovartis Pharma K.K.264